GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

Wiltrom Co 6767.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

23.55

-0.84%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Wiltrom Co

Its shares trade on Taipei Exchange under the ticker 6767.TWO. It has been listed since 5 December 2019. In the fiscal year to 31 December 2025, it reported revenue of TWD 311.8m and a net loss of TWD 19.1m. At that date it held total assets of TWD 710.7m and shareholders' equity of TWD 572.7m.

Wiltrom Co., Ltd. engages in the research, production of various high-end, implantable, Class II, and Class III medical devices. The company is headquartered in Zhubei, Hsinchu. The company went IPO on 2019-12-05. The main products are spinal fixators, artificial bones and interbody fusion cages. The firm's products are mainly focused on three parts including spinal fusion surgery related products, spinal compression fracture surgery products and bone cement products. The firm distributes its products mainly in Taiwan, Asia, America and other places.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
5 Dec 2019

Leadership

Pay as last reported

  • Mr. Huangqian LiangChairman of the Board, General Manager, since 2009
  • Huiwen XiaoChief Financial Officer, Head of Accounting, Corporate Governance Officer, since 2023
  • Mr. Yijun SuChief Operating Officer, Director, since 2009
  • Mr. Deyang CaiChief Legal Officer
  • Mr. Chun-Nan LinDirector
  • Mr. Weizhi ChenIndependent Director
  • Huixian JiangIndependent Director
  • Mr. Jen-Wei KoIndependent Director
  • Mr. Tianren LiuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Wiltrom Co Ltd focuses on high-end implantable medical devices in Class II and III categories.
  • Spinal fusion surgery products are a key focus area for the company's main offerings.
  • Distribution across Taiwan, Asia, and America supports global market reach.

Weaknesses

  • The company's products are limited to spinal surgery and bone cement applications.
  • No mention of international expansion beyond current markets in the facts.
  • Class II and III medical devices require strict regulatory approvals globally.

Opportunities

  • Growing demand for spinal fusion surgery products in Asia and America markets.
  • Potential for expanding into new medical device segments within Health Care.
  • Increasing focus on bone cement products in spinal compression fracture surgery.

Threats

  • Regulatory challenges for Class III medical devices in international markets.
  • Competition from established medical device manufacturers in Asia.
  • Economic fluctuations affecting healthcare spending in America and Asia.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.